This medicine prevents strokes, it is also used to treat thrombosis and pulmonary embolism
(MÉRIDA, YUC. – COFEPRIS).- On Friday, February 18th, Cofepris warned about the counterfeiting of the drug known as Xarelto (rivaroxaban), detecting three counterfeit batches that put patients who receive them throughout the country, at risk .
The Federal Commission for the Protection against Sanitary Risks (Cofepris) reported that inconsistencies were identified in three false batches of this anticoagulant produced by Bayer de México.
Any user or business in México who has this medicine in their hands should check if it does not belong to batches BXJG6V2 and BXJG6V3 , which are considered fake and adulterated if they contain 14 tablets, the original medicine comes in a 28-tablets presentation.
The packages also present anomalies in colors and fonts.
In the case of lot 765289 , the packaging indicates that it has 100 capsules, however, the original medicine does not have that quantity.
Cofepris invited the people who administer or consume this substance to review the identification numbers indicated above to rule out any health risk.
In addition, it recommended suspending its consumption immediately, in case of having counterfeit products since, by not knowing the origin of its components and the manufacturing conditions, it represent a health risk.
What is Xarelto used for?
Xarelto is Bayer Mexico’s brand for the medicine rivaroxaban, which is indicated to treat deep vein thrombosis and pulmonary embolism.
Rivaroxaban is also used to prevent serious strokes or blood clots in people who have atrial fibrillation, a condition in which the heart beats irregularly, making clots more likely to form in the body and possibly causing a stroke. .
It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), and to prevent these blood clots from coming back in the blood vessels of legs and/or lungs.
Xarelto belongs to a group of medicines called antithrombotic agents. It works by blocking a coagulation factor (factor Xa) and therefore reducing the tendency of the blood to form a clot.
The Yucatan Times
more recommended stories
Influenza season ends with six deaths in Yucatan
The 2021-2022 seasonal influenza season concluded.
Bull escapes and injures a seven-year-old boy in Espita Yucatán
On Friday May 20th, a bull.
Due to excessively expensive municipal operating licenses, tourists and locals were left without beer in Progreso, Yucatan
After all the Six beer agencies.
Covid-19 in Yucatan: ”The pandemic is not over yet”, expert warns about summer vacations
The gradual rebound in Covid-19 infections.
IMSS Yucatan makes a public recognition to Nursing Staff
The Mexican Institute of Social Security.
Xcaret postpones the 14th edition of the Sacred Maya Journey
The return of the traditional Sacred.
A woman is crushed to death when a tree falls on top of her car on the Mérida-Valladolid highway
A strange accident happened on Thursday,.
With these local flowers, you help prevent the loss of bees in Yucatan
Every May 20, World Bee Day.
US government officials talk about UFOs publicly for the first time in 50 years
Two senior U.S. defense intelligence officials.
The US Embassy to invest 30 million USD in the “South of Mexico Generating Employment and Sustainability” program
In alliance with seven governments from.